← Leaderboards
Nathan J Wlodarchak
Va Eastern Colorado Health Care System
$0
Attributed
$0
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2022–25$1$1$1$0$0
'22
'23
'24
'25
Funding mix
By agency
VA$0 · 1
By mechanism
IK2$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Combat”
- Alpha Albert Lee · Sloan-Kettering Inst Can Research$33,555,942
- Peter Sjã · Sloan-Kettering Inst Can Research$22,733,967
- Jennifer L. Kraschnewski · Pennsylvania State Univ Hershey Med Ctr$10,233,932
- Urs Oschner · Crestone, Inc.$8,499,692
- Rick L. Stevens · University Of Chicago$7,200,000
- Andrew Tomaras · Forge Therapeutics, Inc.$6,265,409
Research focus
CombatAmericanActinobacteria ClassClinical TreatmentAntibioticsAreaAntibiotic ResistanceBacterial Antibiotic ResistanceAffectAntibiotic Resistant InfectionsBeta-Lactam ResistanceBeta-LactamsBindingBiochemicalAwardBurden Of IllnessCareerCell GrowthCellsBacterial InfectionsCell WallClinical DevelopmentClinically RelevantComplement
Grant awards (4)
Targeting Bacterial Signaling Cascades as a Novel Antibiotic Strategy$0
IK2 · FY2025 · VA · contact PI
Targeting Bacterial Signaling Cascades as a Novel Antibiotic Strategy$0
IK2 · FY2024 · VA · contact PI
Targeting Bacterial Signaling Cascades as a Novel Antibiotic Strategy$0
IK2 · FY2023 · VA · contact PI
Targeting Bacterial Signaling Cascades as a Novel Antibiotic Strategy$0
IK2 · FY2022 · VA · contact PI